← Back to Search

Neuromodulation

Transcranial direct current stimulation for Young Adults

N/A
Recruiting
Research Sponsored by Butler Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 weeks
Awards & highlights

Study Summary

This trial is testing whether they can change brain networks related to response inhibition in healthy young adults, which may help improve treatments for disorders that have difficulties with inhibitory control.

Who is the study for?
This trial is for healthy young adults who either have very good or poor inhibitory control, as measured by the BRIEF-Inhibit scale. Participants must speak English fluently. Those with active mania, psychosis, substance abuse disorders, psychiatric medications, inability to undergo MRI, certain medical conditions like epilepsy or brain injuries, and women not using contraception are excluded.Check my eligibility
What is being tested?
The study investigates how transcranial direct current stimulation (tDCS) affects brain networks and behavior related to response inhibition in healthy young adults. It aims to understand the brain's role in inhibitory control which could improve treatments for disorders where such control is compromised.See study design
What are the potential side effects?
Potential side effects of tDCS may include discomfort at the electrode site on the scalp, itching or tingling during stimulation, headache after treatment sessions, fatigue or nausea. Serious side effects are rare but can include seizures if pre-existing conditions are present.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
fMRI connectivity at rest
fMRI connectivity during a stop signal task

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Placebo Group
Group I: Impulsive Participants- Active StimulationExperimental Treatment1 Intervention
Participants who have high scores on a self-report of inhibitory control abilities (BRIEF-Inhibit) who are randomized to active stimulation.
Group II: Cautious ParticipantsActive Control1 Intervention
Participants who have low scores on a self-report of inhibitory control abilities (BRIEF-Inhibit).
Group III: Impulsive Participants- Sham StimulationPlacebo Group1 Intervention
Participants who have high scores on a self-report of inhibitory control abilities (BRIEF-Inhibit) who are randomized to sham stimulation.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Transcranial direct current stimulation
2012
Completed Phase 3
~650

Find a Location

Who is running the clinical trial?

Butler HospitalLead Sponsor
129 Previous Clinical Trials
16,310 Total Patients Enrolled

Media Library

Transcranial direct current stimulation (Neuromodulation) Clinical Trial Eligibility Overview. Trial Name: NCT04247334 — N/A
Young Adults Research Study Groups: Cautious Participants, Impulsive Participants- Active Stimulation, Impulsive Participants- Sham Stimulation
Young Adults Clinical Trial 2023: Transcranial direct current stimulation Highlights & Side Effects. Trial Name: NCT04247334 — N/A
Transcranial direct current stimulation (Neuromodulation) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04247334 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any limits to the amount of participants involved in this clinical investigation?

"Affirmative. According to information available on clinicaltrials.gov, this medical experiment is in pursuit of 108 participants and will take place at a single site. The trial was initially announced on November 14th 2019 and has been updated as recently as September 8th 2021."

Answered by AI

Are there any openings available for participants in this medical trial?

"The trial is currently in the process of recruitment; according to information hosted on clinicaltrials.gov, this endeavor was first posted on November 14th 2019 and recently revised as of September 8th 2021."

Answered by AI

Am I eligible to be included in this medical study?

"This experiment is looking for 108 participants aged 18-24 who exhibit either low (<1sd below the mean on the BRIEF-Inhibit) or high (>1sd above the mean on BRIEF-Inhibit scale)."

Answered by AI

Does the age qualification for this research project restrict those under 20 years old?

"Those who wish to partake in this study must be older than 18 years and younger than 24 years."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Inhibitory Control: Effects of Modulation
2019. "Inhibitory Control: Effects of Modulation". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04247334.
~20 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top